GGrantIndex
Sort

10,766 grants matching checkpoint inhibitor

Immunology Research Program

$45,950
Jonathan Stuart Serody · Univ Of North Carolina Chapel Hill · P30 · FY2023 · CA

Immunology Research Program

$45,950
Jonathan Stuart Serody · Univ Of North Carolina Chapel Hill · P30 · FY2021 · CA

Assessing TGF Beta1-Mediated ECM Remodeling in Metastatic Oral Squamous Cell Carcinoma

$45,858
John Aleman · University Of Colorado Denver · F31 · FY2025 · DE

T cell expressed miR-155 promotes antitumor immunity and immune checkpoint blockade responses in colon cancer through repression of Ship1

$45,850
William Weihao Tang · University Of Utah · F30 · FY2022 · CA

PIKfyve regulation of IL-12 signaling in dendritic cells and cancer immunity

$45,839
Jae Eun Choi · University Of Michigan At Ann Arbor · F31 · FY2021 · CA

Targeted radionuclide therapy for tumor immunomodulation and enhancing immunotherapy response

$45,705
Caroline Paula Anne Kerr · University Of Wisconsin-Madison · F30 · FY2024 · CA

Gene and Virus Therapy Program

$45,693
Evanthia Galanis · Mayo Clinic Rochester · P30 · FY2020 · CA

Balancing Efficacy and Toxicity of Intratumoral Reolysin for Diffuse Intrinsic Pontine Glioma (DIPG)

$45,667
Matthew Schuelke · Mayo Clinic Rochester · F30 · FY2020 · CA

Reprogramming Liver Macrophages for Sex-based Hepatocellular Carcinoma Immunotherapy

$45,660
Sumit Saha · Virginia Commonwealth University · F99 · FY2025 · CA

Enabling technologies to study how mechanics influence T cell function at the molecular and cellular levels

$45,544
Pui-Yan Victor Ma · Emory University · F99 · FY2017 · CA

The Effects of Obesity on the Efficacy of Immunotherapy

$45,540
Stephanie Dudzinski · Vanderbilt University · F30 · FY2019 · CA

Identifying mechanisms of response and resistance to immunotherapies in lung cancer

$45,520
Camila Robles-Oteiza · Yale University · F99 · FY2020 · CA

Targeting Serine and Glycine Metabolic Vulnerabilities in Melanoma Brain Metastasis

$45,520
Victoria Margarita Osorio Vasquez · New York University School Of Medicine · F31 · FY2020 · CA

The Role of Checkpoint inhibitors in CIA

$45,520
Megan Kay Wood · Johns Hopkins University · F31 · FY2020 · AR

Genome Integrity Through the Cell Cycle in Homeostasis and Cancer

$45,520
Zachary Kenneth Mirman · Rockefeller University · F99 · FY2020 · CA

Tumor Intrinsic Regulation of Immune Evasion Pathways in Melanoma

$45,520
Sheera Rosenbaum · Thomas Jefferson University · F99 · FY2020 · CA

Neuropilin-1 Stabilizes Human Tregs in Cancer Patients Thereby Enhancing Suppressive Function

$45,520
Christopher Chuckran · University Of Pittsburgh At Pittsburgh · F31 · FY2020 · CA

Sensitizing Colorectal Cancer to Checkpoint Inhibitors by WNT Pathway Suppression

$45,520
Alyna Katti · Weill Medical Coll Of Cornell Univ · F31 · FY2020 · CA

Regulation of inhibitory DAMP to harness immunogenic cell death

$45,520
Kazukuni Hayashi · Cedars-Sinai Medical Center · F31 · FY2020 · CA

Effect of APOBEC3 on Bladder Cancer Biology and Response to Immunotherapy

$45,520
Andrew Truong · Univ Of North Carolina Chapel Hill · F31 · FY2020 · CA

DNA mechanotechnology to investigate the role of PD1 biophysics in T cell signaling

$45,520
Anna Kellner · Emory University · F31 · FY2020 · CA

Role of ER stress-driven IRE1α-XBP1 Signaling in Lung Cancer Pathogenesis

$45,520
Michael Joseph Crowley · Weill Medical Coll Of Cornell Univ · F31 · FY2020 · CA

Rebalancing protein homeostasis enhances tumor antigen presentation

$45,520
Grissel Cervantes Jaramillo · Massachusetts Institute Of Technology · F31 · FY2020 · CA

Harnessing the innate immunotransmitter cGAMP for anti-cancer therapy

$45,520
Jacqueline Carozza · Stanford University · F31 · FY2020 · CA

Development of Immunotherapy for Medullary Thyroid Cancer

$45,500
Ravi Madan · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA